Adaptive Biotechnologies ADPT Inventory write-downs
Inventory write-downs at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:InventoryWriteDown.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's inventory write-downs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's inventory write-downs?
- Adaptive Biotechnologies (ADPT) reported inventory write-downs of -$10K in Q1 2026.
- How has Adaptive Biotechnologies's inventory write-downs changed year-over-year?
- Adaptive Biotechnologies's inventory write-downs increased by 90.1% year-over-year, from -$101K to -$10K.
- What does inventory write-downs mean?
- This represents the non-cash expense recognized when the carrying value of inventory is reduced to its net realizable value due to obsolescence, damage, or market price declines. It is added back to net income in the operating cash flow calculation as it does not involve a cash payment. High levels of write-downs can indicate inefficiencies in inventory management or potential product demand issues.